Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized vs Liquid IMVAMUNE Smallpox Vaccine
NCT00914732Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2010
- Primary completion
- Apr 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of JYNNEOS in smallpox, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2010; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00914732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914732.